Jevtana is an antineoplastic drug recommended for treatment of castrate resistant metastatic prostate cancer. Cabazitaxel is generic version of Jevtana. The drug is administered intravenously, also, it is used together with prednisone.
The Jevtana Market is driving due to increasing prevalence of prostate cancer and growing adoption of chemotherapies. However, increased risk of adverse effects caused due to the drug are likely to hamper the growth of the global Jevtana Market.
The "Jevtana Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Jevtana Market with detailed market segmentation by type and end user. The Jevtana Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Jevtana Market and offers key trends and opportunities in the market.
The Jevtana Market is segmented on the basis of type and end user. Based on type, the market is segmented as 99% purity and others. On the basis of end user, the market is segmented as hospitals, cancer centers, and other end users.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Jevtana Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Jevtana Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Jevtana Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Jevtana Market in these regions.
Get more information on this report :
The report covers key developments in the Jevtana Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Jevtana Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Jevtana Market.
The report also includes the profiles of key players in Jevtana Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Fuan Pharmaceutical Group
Fujian Yewpark Biological
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
The List of Companies
2. Tapi Teva
3. Fuan Pharmaceutical Group
4. Fujian Yewpark Biological